Informative Report On (COVID-19 Updates) Antibodies Market is Generating Revenue of $384.0 Billion by 2027, at CAGR 12.6% Growth Rate

Overview

An antibody, also known as immunoglobulin, is a plasma cell which is released in response to antigens. For a variety of indications, including tumors, autoimmune conditions, allergic and contagious diseases, among others, these antibodies may be used therapeutically as well as diagnostically.

The global antibodies market is valued at US$ 147,385.1 million and is forecast to grow to US$ 384,011.6 million by the end of 2027.

Request a sample copy of help grow your business @
https://www.coherentmarketinsights.com/insight/request-sample/2629

Drivers

Oncology, neurobiology, autoimmunology, and cardiology all use therapeutic monoclonal antibodies. The global antibodies market is expected to rise in response to the rising prevalence of chronic diseases. As per the World Health Organization, cancer caused about 18.1 million new cases and 9.6 million deaths worldwide in 2018.

Furthermore, the advent of low-cost bio-similar antibody therapeutics is expected to help the global antibodies market’s development. The World Health Organization (WHO) prequalified trastuzumab, a monoclonal antibody for the treatment of early stage breast cancer, as its first bio-similar drug in December 2019. Trastuzumab costs about $20,000 on average.

In 2018, the North American region dominated the global antibodies market, contributing about 44.5 percent of the market's size, led by Europe.

Opportunities

Several successful antibody drugs are due to lose their patents in the coming future. As a result, main industry players will concentrate on releasing bio-similar antibodies in order to increase their market share.

Furthermore, in developing markets, the evolution of a simple regulatory approval mechanism for bio-similars provides an additional opportunity for antibody-based drugs. The Central Drugs Standard Control Organization of the Government of India published regulatory standards for marketing clearance of related biologics in India in 2012, which were updated in 2016 for greater clarification. As per the revision, the reference somatic mutation could be licensed or sold in India or any other country that is a member of the International Council for Harmonization.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report @
https://www.coherentmarketinsights.com/insight/buy-now/2629

Market Trends

Antibody-based treatments for cancer therapy have seen a huge rise in popularity. Monoclonal antibody therapeutics have high sensitivity, activity, pharmacokinetics, and production methods that are standardized. Antibodies can also boost the immune reaction to cancer cells by causing complement-dependent or antibody-dependent cellular cytotoxicity.

Antibodies are no longer used as analytical reagents for the detection of disease signs or proteins using immunoassays. The increasing precision of molecular diagnostic instruments is to be accounted for this.

Competitive Landscape

Key companies contributing in the global antibodies market are Biogen Inc., AbbVie Inc., Eli Lilly and Co., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc., Novartis AG, Kyowa Kirin Co., Ltd., F. Hoffmann-La Roche Ltd., Ultragenyx Pharmaceutical Inc., Amgen Inc., Iovance Biotherapeutics, Inc., Sanofi, and Bristol-Myers Squibb Company.

Detailed Segmentation

By Product Type:

Monoclonal antibodies

Polyclonal antibodies

Antibody-drug complexes (ADCs)

By Disease Indication:

CNS Disorders

Cardiovascular Diseases

Cancer

Autoimmune Disorders

By End User:

Hospitals

Long-term Care Facilities

Research institutes

Request PDF Brochure of help grow your business @
https://www.coherentmarketinsights.com/insight/request-pdf/2629

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact us:

Mr. Shah
Senior Client Partner – Business Development
sales@coherentmarketinsights.com